SAMSARA BIOCAPITAL, LLC
PALO ALTO, CA · CIK 1744967 · 13F filing filed 2024-08-14
SEC-registered investment adviser since 2018 · limited liability company
- Assets managed$2.2bn
- Staff31 · 22 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds3 · $2.3bn gross assets
- Websitesamsaracap.com
- Form ADV · 2026-06-26SEC adviser record
- Kindventure
- Others nearbyPalo Alto, CA
As an employer
- Private fundsventure capital 3
US visa salary filings
- Filings FY20242
- Median salary offered$187,500
- Middle half$181,250 – $193,750
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Senior AssociatePalo Alto, CA | 2 | $187,500 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.
$477.8m
reported value
-26.1% vs Q1 2024
40positions
73.6%in top 10
3 new
3 added
3 reduced
2 sold out
vs Q1 2024
Holdings, Q2 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CARGO THERAPEUTICS INC COM | $72.5m15.17% | Added +294.0k |
| MINERALYS THERAPEUTICS INC MLYS | $59.4m12.43% | Unchanged |
| SCHOLAR ROCK HLDG CORP SRRK | $56.5m11.84% | Unchanged |
| NEUROGENE INC NGNE | $46.1m9.66% | Unchanged |
| ARCELLX INC ACLX | $25.0m5.24% | Unchanged |
| CLIMB BIO INC CLYM | $23.2m4.85% | New |
| NKARTA INC NKTX | $22.3m4.66% | Unchanged |
| LENZ THERAPEUTICS INC LENZ | $20.9m4.37% | Unchanged |
| AVADEL PHARMACEUTICALS PLC AVDL | $13.6m2.85% | New |
| JASPER THERAPEUTICS INC JSPR | $11.9m2.49% | Unchanged |
| HILLEVAX INC COM | $11.6m2.42% | Unchanged |
| ABIVAX SA ABVX | $11.2m2.35% | Unchanged |
| ACELYRIN INC COM | $11.1m2.33% | Unchanged |
| CONTINEUM THERAPEUTICS INC CTNM | $10.4m2.17% | New |
| SYROS PHARMACEUTICALS INC SYRS | $9.2m1.93% | Unchanged |
| ZYMEWORKS INC ZYME | $8.5m1.78% | Reduced -458.9k |
| RHYTHM PHARMACEUTICALS INC RYTM | $7.1m1.48% | Unchanged |
| INOZYME PHARMA INC COM | $7.0m1.46% | Unchanged |
| SUTRO BIOPHARMA INC COM | $6.4m1.35% | Added +521.2k |
| GOSSAMER BIO INC GOSS | $5.5m1.16% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $5.4m1.13% | Unchanged |
| VERONA PHARMA PLC VRNA | $5.0m1.05% | Unchanged |
| LEAP THERAPEUTICS INC CYPH | $4.8m1.00% | Added +1.8m |
| IO BIOTECH INC IOBTQ | $4.3m0.89% | Unchanged |
| VTV THERAPEUTICS INC VTVT | $3.7m0.76% | Unchanged |
| PRIME MEDICINE INC PRME | $2.8m0.58% | Unchanged |
| DAY ONE BIOPHARMACEUTICALS I COM | $2.7m0.57% | Unchanged |
| IMMATICS N.V IMTX | $2.3m0.48% | Reduced -198.0k |
| JANUX THERAPEUTICS INC JANX | $1.9m0.39% | Reduced -135.2k |
| TERNS PHARMACEUTICALS INC COM | $1.4m0.29% | Unchanged |
| IGM BIOSCIENCES INC IGMS | $1.1m0.22% | Unchanged |
| BOLT BIOTHERAPEUTICS INC COM | $786.9k0.16% | Unchanged |
| LYRA THERAPEUTICS INC LYRA | $769.3k0.16% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $765.8k0.16% | Unchanged |
| VIRACTA THERAPEUTICS INC SNSS | $375.0k0.08% | Unchanged |
| ALLAKOS INC ALLKG | $172.1k0.04% | Unchanged |
| KRONOS BIO INC KRON | $96.9k0.02% | Unchanged |
| ALLOVIR INC COM | $59.6k0.01% | Unchanged |
| NUVATION BIO INC NUVB.WS | $21.3k0.00% | Unchanged |
| SURROZEN INC *W EXP 08/01/203 | $1.7k0.00% | Unchanged |
Sold out since Q1 2024
| Security | Value then |
|---|---|
| AVADEL PHARMACEUTICALS PLC | $16.3m967.5k shares |
| ADVERUM BIOTECHNOLOGIES INC ADVM | $4.1m291.7k shares |